Jennifer Ernst, CEO of Tivic Health™ Systems Inc., a commercial phase bioelectronic company, will present at the MedTech Strategist Innovation Summit San Francisco 2019 Conference, taking place November 18-19 at the Hyatt Regency in Burlingame.
SAN FRANCISCO, Nov. 18, 2019 /PRNewswire/ -- Jennifer Ernst, CEO of Tivic Health™ Systems Inc., a commercial phase bioelectronic company, will present at the MedTech Strategist Innovation Summit San Francisco 2019 Conference, taking place November 18-19 at the Hyatt Regency in Burlingame. The Innovation Summit will feature presentations by more than 30 medtech start-ups showcasing their latest innovations along with a conference program highlighting today's thriving global medical device ecosystem. In her presentation, Ernst will focus on bioelectronics, an emerging form of drug-free, non-invasive medicine that uses low-level electrical stimulation, or neuromodulation, to treat chronic conditions and diseases. She will also discuss the company's successful September launch of ClearUP® Sinus Pain Relief, an FDA cleared, over-the-counter device that treats sinus pain due to allergic rhinitis – seasonal and year-round allergies. "I'm delighted to be participating in the Innovation Summit with a distinguished group of new companies all focused on developing next generation medical devices," said Ernst. "Innovative advances in neuromodulation devices, including sensing, novel waveforms, and personalization are enhancing efficacy and accelerating the integration of neuromodulation therapies in medicine. Our team is dedicated to providing readily accessible, at-home solutions to treat chronic diseases and conditions." About ClearUP Sinus Pain Relief About Tivic Health Systems Inc.
SOURCE Tivic Health Systems Inc. |